{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-037619","form_type":"8-K","ticker":"ZVRA","cik":"0001434647","company_name":"ZEVRA THERAPEUTICS, INC.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.618602+00:00","generated_at":"2026-05-26T01:29:22.127731+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Zevra sells PRV for $150M cash; funds MIPLYFFA & OLPRUVA launches","bullets":["Gross proceeds of $150M, payable in cash at closing; expected within 30-45 days.","PRV granted in Sep 2024 upon FDA approval of MIPLYFFA for Niemann-Pick type C.","Transaction subject to HSR waiting period expiration; Cantor Fitzgerald advised.","CFO states non-dilutive capital strengthens balance sheet, supports commercial launches and pipeline."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-037619","json":"https://secwatch.observer/filing/0001193125-25-037619.json","markdown":"https://secwatch.observer/filing/0001193125-25-037619.md","text":"https://secwatch.observer/filing/0001193125-25-037619.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434647/000119312525037619/0001193125-25-037619-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434647/000119312525037619/d928575d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T01:29:22.127731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}